Abstract
Antibiotics developed over the past quarter century have greatly improved toxic to therapeutic ratios compared to older agents. This is due to both a wider spectrum of in vitro antibacterial activity and less frequent side effects. In combination with once daily dosing and nearly complete bioavailability of some newer agents, the better risk to benefit ratios have led to empiric antibiotic use in many situations even when bacterial infections are not likely. Many newer antibiotics are not often considered toxic, although their side effects have been documented in medical literature, and several antibiotics that were considered very safe have been removed from the market or their use severely restricted within a relatively short time after their introduction. An understanding of the frequency and mechanism of unintended effects helps physicians minimize them, treat them quickly and effectively when they occur, and even avoid them. Drug interactions and potential adverse effects of β-lactam antibiotics, penicillins, cephalosporins, and carbapenems, are presented.
Keywords: allergies, penicillins, cephalosporins,, carbapenem antibiotics, antibacterial activity, lactam antibiotics
Current Pharmaceutical Design
Title: Separating Fact from Fiction: The Data Behind Allergies and Side Effects Caused by Penicillins, Cephalosporins, and Carbapenem Antibiotics
Volume: 9 Issue: 12
Author(s): Ira Leviton
Affiliation:
Keywords: allergies, penicillins, cephalosporins,, carbapenem antibiotics, antibacterial activity, lactam antibiotics
Abstract: Antibiotics developed over the past quarter century have greatly improved toxic to therapeutic ratios compared to older agents. This is due to both a wider spectrum of in vitro antibacterial activity and less frequent side effects. In combination with once daily dosing and nearly complete bioavailability of some newer agents, the better risk to benefit ratios have led to empiric antibiotic use in many situations even when bacterial infections are not likely. Many newer antibiotics are not often considered toxic, although their side effects have been documented in medical literature, and several antibiotics that were considered very safe have been removed from the market or their use severely restricted within a relatively short time after their introduction. An understanding of the frequency and mechanism of unintended effects helps physicians minimize them, treat them quickly and effectively when they occur, and even avoid them. Drug interactions and potential adverse effects of β-lactam antibiotics, penicillins, cephalosporins, and carbapenems, are presented.
Export Options
About this article
Cite this article as:
Leviton Ira, Separating Fact from Fiction: The Data Behind Allergies and Side Effects Caused by Penicillins, Cephalosporins, and Carbapenem Antibiotics, Current Pharmaceutical Design 2003; 9 (12) . https://dx.doi.org/10.2174/1381612033455143
DOI https://dx.doi.org/10.2174/1381612033455143 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update on the Therapy of Behçets Disease
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents β-Lactams as Neuroprotective Agents
Anti-Infective Agents in Medicinal Chemistry Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Allopurinol Hypersensitivity Reactions: Desensitization Strategies and New Therapeutic Alternative Molecules
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology TB Diagnostics – Old and New
Current Respiratory Medicine Reviews Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Caspase-3 Short Hairpin RNAs: A Potential Therapeutic Agent in Neurodegeneration of Aluminum-Exposed Animal Model
Current Alzheimer Research Nutritional Requirements for Maternal and Newborn Health
Current Women`s Health Reviews Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Current Concepts in SLE Thrombocytopenia: From Pathophysiology to Therapeutic Interventions
Current Rheumatology Reviews Synergistic Activities of a Silver(I) Glutamic Acid Complex and Reactive Oxygen Species (ROS): A Novel Antimicrobial and Chemotherapeutic Agent
Current Medicinal Chemistry Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Immune Responses to Adenovirus and Adeno-Associated Vectors Used for Gene Therapy of Brain Diseases: The Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune Interactions
Current Gene Therapy Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design Editorial: “Phytochemicals for Human Diseases: An Update”
Current Drug Targets